| LOVFF Stock | | | USD 0.51 0.03 5.56% |
Insider
David Abitbol is VP Marketing of Cannara Biotech
| Phone | 514 543 4200 |
| Web | https://cannara.ca |
Cannara Biotech Management Efficiency
The company has return on total asset
(ROA) of
0.0327 % which means that it generated a profit of $0.0327 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0434 %, meaning that it generated $0.0434 on every $100 dollars invested by stockholders. Cannara Biotech's management efficiency ratios could be used to measure how well Cannara Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
Cannara Biotech has accumulated 46.19
M in total debt with debt to equity ratio
(D/E) of 0.49, which is about average as compared to similar companies. Cannara Biotech has a current ratio of 2.09, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Cannara Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Cannara Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannara Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannara to invest in growth at high rates of return. When we think about Cannara Biotech's use of debt, we should always consider it together with cash and equity.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. Cannara Biotech is traded on OTC Exchange in the United States. Cannara Biotech [LOVFF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Cannara Biotech Leadership Team
Elected by the shareholders, the Cannara Biotech's board of directors comprises two types of representatives: Cannara Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cannara. The board's role is to monitor Cannara Biotech's management team and ensure that shareholders' interests are well served. Cannara Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cannara Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cannara Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Cannara Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Cannara OTC Stock
Cannara Biotech financial ratios help investors to determine whether Cannara OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannara with respect to the benefits of owning Cannara Biotech security.